Overview

Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of glufosfamide when administered in combination with gemcitabine.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Threshold Pharmaceuticals
Collaborator:
PPD
Treatments:
Gemcitabine
Ifosfamide